5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow Narcolepsy Without Cataplexy: new trials by email Literature Review of Narcolepsy Without Cataplexy trials Research Report on Narcolepsy Without Cataplexy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy Mazindol - Narcolepsy With Cataplexy, Narcolepsy | Phase 2 | Completed | NLS Pharmaceutics | 52 | 2021-10-26 | 2023-03-13 |
| Clarithromycin Mechanisms in Hypersomnia Syndromes Clarithromycin, Placebo - Narcolepsy Without Cataplexy, Idiopathic Hypersomnia | Phase 2 | Completed | Emory University | 83 | 2019-09-04 | 2026-08-07 |
| Modafinil Versus Amphetamines for the Treatment of Narcolepsy Type 2 and Idiopathic Hypersomnia Modafinil, Amphetamine-Dextroamphetamine - Idiopathic Hypersomnia, Narcolepsy Without Cataplexy | Phase 2 | Completed | Emory University | 44 | 2019-04-15 | 2024-05-23 |
| A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2 BTD-001, Placebo - Idiopathic Hypersomnia, Narcolepsy Without Cataplexy | Phase 2 | Completed | Balance Therapeutics | 120 | 2015-09-01 | 2019-01-16 |
| Flumazenil for the Treatment of Primary Hypersomnia Flumazenil - Hypersomnia, Primary Hypersomnia | Phase 1 / Phase 2 | Completed | Lynn Marie Trotti | 10 | 2010-09-01 | 2017-12-12 |
Idiopathic Hypersomnia (4) · Narcolepsy (2) · Disorders of Excessive Somnolence (1)
Dyssomnias (5) · Mental Disorders (5) · Nervous System Diseases (5) · Sleep Disorders, Intrinsic (5) · Sleep Wake Disorders (5) · Disorders of Excessive Somnolence (4)
Adderall (1) · Clarithromycin (1) · Flumazenil (1) · Mazindol (1) · Modafinil (1) · SLI381 (1)
Emory University (2) · Balance Therapeutics (1) · Lynn Marie Trotti (1) · NLS Pharmaceutics (1)
United States (5)
Lynn Marie Trotti, MD, MSc (2) · Carlos Camozzi, MD (1) · Lyndon Lien, PhD (1) · Lynn Marie Trotti, MD (1)
R01NS111280 (1)